Login to Your Account

Other News To Note

Wednesday, October 2, 2013
• Bergenbio AS, of Bergen, Norway, published a paper in Blood identifying a significant role for the Axl receptor in progression and therapeutic resistance of acute myelogenous leukemia (AML).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription